💫 Exciting news! Our B7H3xCD3 #bispecific#antibody CC-3 shows promise in fighting bone & soft tissue sarcomas. Congrats to Samuel Holzmayer & team! @MMaerklin@CoE_iFIT#immunotherapy
➡️https://t.co/MGPT9YDAF2
Happy to announce that Jens Bauer from our lab together with Ashish Goyal and Joschka Hey were awarded the #WaltraudLewenzPreis 2023 @DKFZ for their work on "DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts".
Glad to share our latest paper in @ScienceTM on novel immunocytokines containing mutations to enable target-restricted activity, reducing systemic side effects and enhancing efficacy. Thanks to all contributors!
https://t.co/xozXL1OPJP
🎅🏻 Celebrating our annual #NikolausParty on the 6th! 🎉 Polina Kaidun stole the show as the #MouseKing from #TheNutcracker. 💫
Gratitude to my colleagues for making it memorable and their outstanding work in #2023. Cheers to a fantastic #team! 🎄
Das @SPRIND-Tochterunternehmen BiconY Therapeutics GmbH übernimmt die Finanzierung der Weiterentwicklung von neuen Methoden zur Behandlung von soliden Tumoren mit bispezifischen Antikörpern https://t.co/bqw5Datp8c
A new study compares #SARSCoV2 vaccines in people, suggesting that boosters did not vastly improve T cell responses—which were already sufficiently robust—but did improve antibody reactions. @uni_tue@YMaringer@LabWalz
📄: https://t.co/j0OQ23jFgY
We are very excited to share our work published in @SciImmunology showing that different #vaccination regimens induce broad and long-lasting spike-specific CD4+ and CD8+ #Tcell immunity that is not further enhanced by booster vaccination: https://t.co/BxRhJypCYV
An oncogenic fusion protein as target for novel #immunotherapies of cancer. We are so excited to share our study, which identified the
oncogenic fusion protein DNAJB1-PRKACA as source of #neoantigens for peptide-based immunotherapy in #FLHCC!
https://t.co/T4D6ePqgBv
It is a great honour to receive the second year in a row the @dgho_eV Best Abstract #award for our work on developing a #COVID19 T cell activator for #Cancer#patients with B cell deficiency.
Congratulations to @JulianeWalz on receiving the “Best Abstract” award! #DGHO2022
She reported on our #COVID19 vaccine candidate CoVac-1 for (cancer) patients with B cell deficiency at the @dgho_eV Annual Meeting in Vienna.
@LabWalz
Please don't just watch us get killed online. It's not a show. It's our lives, millions of lives. Act!
Please help us win. Help us stay alive.
Give us combat planes and air defense systems.
Delay is paid for in human lives.
Hint to my EU friends:
Putin is getting money for oil and gas (and EU is the largest buyer) via traditional banking transfers, not via crypto.
Russian opposition who fight Putin get money from supporters via crypto, not via traditional banking transfers.
Please, do the math.
@mironov_fm местные говорят, что это правда, буквально на днях от коллег слышал. 😅 дрова-то лежат огромными кучами прямо в поле. говорят некоторые GPS треккеры стали в поленницы класть